Home
About Us
The KIS Foundation, Inc.
Our Mission Statement
The Founder
Board Of Directors
Advisory Board
Sickle Cell Disease
By The Definition
In The News
In The Community
Hindsight Series
Programs & Events
The Crisis Care Package Program
Upcoming Events
Past Events
Resources
Applications & Materials
Press
Photo Gallery
Donate & Give
Make A Donation Now
Give Gifts From The Heart
Volunteer Your Time
Contact Us
Home
About Us
The KIS Foundation, Inc.
Our Mission Statement
The Founder
Board Of Directors
Advisory Board
Sickle Cell Disease
By The Definition
In The News
In The Community
Hindsight Series
Programs & Events
The Crisis Care Package Program
Upcoming Events
Past Events
Resources
Applications & Materials
Press
Photo Gallery
Donate & Give
Make A Donation Now
Give Gifts From The Heart
Volunteer Your Time
Contact Us
April 20, 2024
KiKi Shepard
Dr. Lametra Scott Interview
KiKi Shepard
April 20, 2024
Dr. Lametra Scott Interview
KiKi Shepard
April 20, 2024
Newer Post
SCDAA and MedicAlert Pilot Program
Older Post
New Novartis medicine Adakveo® (crizanlizumab) approved by FDA to reduce frequency of pain crises in individuals living with Sickle Cell Disease